Related Experiment Videos
Systemic mastocytosis--a case treated with interferon alpha and radiotherapy
B D Harrison1, R A Ashford, C S Hatton
1Heatherwood and Wexham Park Hospital Trust, Berks, UK.
Clinical and Laboratory Haematology
|September 1, 1994
Summary
Systemic mastocytosis is rare, causing symptoms from mast cell degranulation. Radiotherapy effectively reduced symptoms in one patient, while interferon alpha did not.
Area of Science:
- Hematology
- Oncology
Background:
- Systemic mastocytosis (SM) is an uncommon hematologic disorder.
- Symptoms arise from mast cell infiltration and degranulation.
Observation:
- Literature reports successful treatment of SM with interferon alpha and radiotherapy.
- This case presents a patient with SM who received both therapies.
Findings:
- The patient responded well to radiotherapy, experiencing symptom and disease reduction.
- Interferon alpha treatment did not yield a positive response in this patient.
Implications:
- Radiotherapy may be a viable treatment option for select systemic mastocytosis patients.
- Treatment response can vary significantly among individuals with SM.